Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.380 | Biomarker | disease | BEFREE | The interaction between serotonin (5-HT) and glucagon-like peptide-1 (GLP-1) could play a role as upstream effectors involved in mediating associations between anorectic and noxious/stressful stimuli. | 30959513 | 2019 | ||||
|
0.380 | Biomarker | disease | BEFREE | Here, we investigated if peripheral co-administration of ADM and glucagon-like peptide 1 (GLP-1) could subdue the hypoglycaemic effects of ADM while enhancing its anorectic properties. | 30396073 | 2019 | ||||
|
0.380 | Biomarker | disease | BEFREE | This molecule combined the beneficial anorectic and glycemic effects of glucagon-like peptide 1 with the thermogenic effect of glucagon into a single molecule with enhanced potency and sustained action. | 30087160 | 2018 | ||||
|
0.380 | Biomarker | disease | BEFREE | Given the role of GLP-1 as a mediator of anorexia under acute sickness conditions, we hypothesized that brainstem GLP-1 signalling might play a role in the mediation of CACS. | 29247677 | 2018 | ||||
|
0.380 | Biomarker | disease | BEFREE | Taken together, our findings suggest that both GLP-1 and CCK play contributory roles in T-2 toxin-induced anorexia. | 29433086 | 2018 | ||||
|
0.380 | Biomarker | disease | CTD_human | Role of Glucagon-Like Peptide-1 and Gastric Inhibitory Peptide in Anorexia Induction Following Oral Exposure to the Trichothecene Mycotoxin Deoxynivalenol (Vomitoxin). | 28633506 | 2017 | ||||
|
0.380 | Biomarker | disease | BEFREE | In conclusion, CCK plays a contributory role in anorexia induction but GLP-1 might play a lesser role in this response. | 28964791 | 2017 | ||||
|
0.380 | Biomarker | disease | BEFREE | Estradiol modulates the anorexic response to central glucagon-like peptide 1. | 28558993 | 2017 | ||||
|
0.380 | Biomarker | disease | BEFREE | Pretreatment with the GLP-1 receptor antagonist Exendin9-39 induced a dose-dependent attenuation of both GLP-1- and DON-induced anorexia. | 28633506 | 2017 |